Management of CMV disease in HIV infection.
Williams
I G
IG
Department of Sexually Transmitted Diseases, Royal Free and University College Medical School, University College London, UK. iwilliams@gum.ucl.ac.uk
D017088:AIDS-Related Opportunistic Infections / Q000628:therapy*; D000998:Antiviral Agents / Q000627:therapeutic use; D000077404:Cidofovir; D003586:Cytomegalovirus Infections / Q000628:therapy*; D017726:Cytomegalovirus Retinitis / Q000628:therapy; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D018792:Encephalitis, Viral / Q000628:therapy; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000628:therapy; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D017245:Foscarnet; D003596:Cytosine; D000077404:Cidofovir; D015774:Ganciclovir